HAMILTON, Ontario and BOSTON, Jan. 11, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as ...

Sarah has been an editor and contributor for Game Rant since 2015. After meeting her first Chocobo, she never looked back. Sarah majored in game design in college and utilizes that knowledge to ...

Kyle has a degree in Film, Television, and Cultural Studies and has loved video games for as long as he can remember. He's owned every PlayStation, dabbled with the occasional Xbox, and even owned a ...

Collaboration enables Fusion to produce high purity actinium-225 at Company's GMP manufacturing facility Agreement furthers BWXT Medical's position as a global leader in medical isotope supply Under ...

Fusion to invest $5M for guaranteed access to actinium-225 supply Agreement augments Fusion's existing supply as company expands pipeline of actinium-based radio pharmaceuticals "As excitement for the ...

The Massachusetts Institute of Technology Plasma Science and Fusion Center is to expand its fusion energy research and education activities under a new five-year agreement with its spinout company ...

Canada’s General Fusion and the UK Atomic Energy Authority will collaborate on projects to "advance the commercialisation of magnetised target fusion energy". General Fusion's vision for its plant of ...

OTTAWA, Ontario--(BUSINESS WIRE)-- BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to ...

Though the field of fusion energy research is dominated by a few major efforts, there are today about 50 privately funded fusion startups in 12 countries that have garnered over US$5.6 billion in ...

The United Kingdom Atomic Energy Authority (UKAEA) has partnered with a council and a private firm to work on designing future experimental fusion power plants. This collaboration includes the Science ...